BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29235659)

  • 1. Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance.
    Mulvahill JS; Nicol GE; Dixon D; Lenze EJ; Karp JF; Reynolds CF; Blumberger DM; Mulsant BH
    J Am Geriatr Soc; 2017 Dec; 65(12):2651-2658. PubMed ID: 29235659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression Remission Rates Among Older Black and White Adults: Analyses From the IRL-GREY Trial.
    Hall CA; Simon KM; Lenze EJ; Dew MA; Begley A; Butters MA; Blumberger DM; Stack JA; Mulsant B; Reynolds CF
    Psychiatr Serv; 2015 Dec; 66(12):1303-11. PubMed ID: 26278231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.
    Saade YM; Nicol G; Lenze EJ; Miller JP; Yingling M; Wetherell JL; Reynolds CF; Mulsant BH
    Depress Anxiety; 2019 Dec; 36(12):1125-1134. PubMed ID: 31682328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.
    Lyndon GJ; Prieto R; Wajsbrot DB; Allgulander C; Bandelow B
    Int Clin Psychopharmacol; 2019 May; 34(3):110-118. PubMed ID: 30870236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.
    Smagula SF; Butters MA; Anderson SJ; Lenze EJ; Dew MA; Mulsant BH; Lotrich FE; Aizenstein H; Reynolds CF
    JAMA Psychiatry; 2015 Oct; 72(10):1021-8. PubMed ID: 26288246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.
    Marshe VS; Maciukiewicz M; Rej S; Tiwari AK; Sibille E; Blumberger DM; Karp JF; Lenze EJ; Reynolds CF; Kennedy JL; Mulsant BH; Müller DJ
    Am J Psychiatry; 2017 May; 174(5):468-475. PubMed ID: 28068779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported obstructive sleep apnea is associated with nonresponse to antidepressant pharmacotherapy in late-life depression.
    Waterman L; Stahl ST; Buysse DJ; Lenze EJ; Blumberger D; Mulsant B; Butters M; Gebara MA; Reynolds CF; Karp JF
    Depress Anxiety; 2016 Dec; 33(12):1107-1113. PubMed ID: 27636232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine.
    Marshe VS; Islam F; Maciukiewicz M; Fiori LM; Yerko V; Yang J; Turecki G; Foster JA; Kennedy SH; Blumberger DM; Karp JF; Kennedy JL; Mulsant BH; Reynolds CF; Lenze EJ; Müller DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109867. PubMed ID: 31954757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic prediction of treatment response in late-life depression.
    Joel I; Begley AE; Mulsant BH; Lenze EJ; Mazumdar S; Dew MA; Blumberger D; Butters M; Reynolds CF;
    Am J Geriatr Psychiatry; 2014 Feb; 22(2):167-76. PubMed ID: 23567441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Prior Treatment on Remission of Late-Life Depression with Venlafaxine and Subsequent Aripiprazole or Placebo Augmentation.
    Hsu JH; Mulsant BH; Lenze EJ; Karp JF; Lavretsky H; Roose SP; Reynolds CF; Blumberger DM
    Am J Geriatr Psychiatry; 2016 Oct; 24(10):918-22. PubMed ID: 27538352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute trajectories of neural activation predict remission to pharmacotherapy in late-life depression.
    Karim HT; Wang M; Andreescu C; Tudorascu D; Butters MA; Karp JF; Reynolds CF; Aizenstein HJ
    Neuroimage Clin; 2018; 19():831-839. PubMed ID: 30013927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A; Roose S
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
    Maneeton N; Maneeton B; Eurviriyanukul K; Srisurapanont M
    Drug Des Devel Ther; 2013; 7():1053-62. PubMed ID: 24101861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR; Huang H; Thase ME
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.